Drugs & Medication

Bills CommitteeLast actionDate
HB 66 - Carter - Health insurance; cost-sharing payments for prescription insulin drugs. (H) Committee on Labor and Commerce

(S) Committee on Commerce and Labor
(S) Referred to Committee on Commerce and Labor02/04/20
notes: Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation.
HB 87 - Carter - Marijuana; legalization of simple possession, penalties. (H) Committee for Courts of Justice(H) Continued to 2021 in Courts of Justice02/05/20
notes: Eliminates criminal penalties for possession of marijuana for persons who are 21 years of age or older. The bill also decriminalizes marijuana possession for persons under 21 years of age and provides a civil penalty of no more than $100 for possession of (i) two and one-half ounces or less of marijuana or (ii) 12 or fewer marijuana plants and a civil penalty of no more than $500 for possession of more than (a) two and one-half ounces of marijuana or (b) 12 marijuana plants. Under current law, a first offense is punishable by a maximum fine of $500 and a maximum jail sentence of 30 days, and subsequent offenses are a Class 1 misdemeanor. The bill also modifies several other criminal penalties related to marijuana. The bill establishes a regulatory scheme for the regulation of marijuana cultivation facilities, marijuana manufacturing facilities, marijuana secure transporters, marijuana testing facilities, retail marijuana stores, and marijuana microbusinesses by the Board of Agriculture and Consumer Services. The bill imposes an additional tax of 10 percent on retail marijuana and retail marijuana products sold by retail marijuana stores and microbusinesses and directs the first $20 million of such revenues, after expenses of the Board are paid, to the Veterans Treatment Fund, established in the bill. The remaining tax receipts will be distributed to the localities in which the businesses operate, toward the state's share of Standards of Quality basic aid payments, and to the Commonwealth Mass Transit Fund. The bill also expands the legal medical uses of marijuana and tetrahydrocannabinol from only cancer and glaucoma to any use to alleviate the symptoms of any diagnosed condition or disease determined by the prescribing
HB 93 - Kory - Flavored tobacco products; sale or distribution prohibited, civil penalty. (H) Committee on Finance(H) Continued to 2021 in Finance02/05/20
notes: Prohibits the sale or distribution of flavored tobacco products, defined in the bill, and creates a civil penalty of $1,000 for a first offense and $5,000 for a second or subsequent offense.
HB 265 - Heretick - Marijuana; decriminalization of simple marijuana possession, civil penalty. (H) Committee for Courts of Justice(H) Incorporated by Courts of Justice (HB972-Herring)02/05/20
notes: Decriminalizes marijuana possession and provides a civil penalty of no more than $25. Under current law, a first offense is punishable by a maximum fine of $500 and a maximum jail sentence of 30 days, and subsequent offenses are a Class 1 misdemeanor. The bill creates a rebuttable presumption that a person who possesses no more than one-half ounce of marijuana possesses it for personal use and provides that the existing suspended sentence and substance abuse screening provisions apply only to criminal violations or to civil violations by a minor. The bill decreases from a Class 5 felony to a Class 6 felony the penalty for distribution or possession with intent to sell more than one-half ounce but not more than five pounds of marijuana.
HB 269 - Heretick - Marijuana; legalization of simple marijuana possession, penalty. (H) Committee for Courts of Justice(H) Continued to 2021 in Courts of Justice02/05/20
notes: Eliminates criminal penalties for possession of marijuana for persons who are 21 years of age or older. The bill also decriminalizes marijuana possession for persons under 21 years of age and provides a civil penalty of no more than $50 for a first violation, $100 for a second violation, and $250 for a third or subsequent violation. Under current law, a first offense is punishable by a maximum fine of $500 and a maximum jail sentence of 30 days, and subsequent offenses are a Class 1 misdemeanor. The bill also modifies several other criminal penalties related to marijuana. The bill establishes a regulatory scheme for the regulation of marijuana cultivation facilities, marijuana manufacturing facilities, marijuana testing facilities, and retail marijuana stores by the Board of Agriculture and Consumer Services. The bill imposes a tax on retail marijuana and retail marijuana products sold by a retail marijuana store at a rate of 9.7 percent (for a total sales tax of 15 percent) and provides that 67 percent of the revenues collected from the tax be deposited into the general fund and 33 percent of the revenues be deposited into a "Retail Marijuana Education Support Fund" to be used solely for purposes of public education.
HB 301 - Levine - Marijuana; decriminalization of simple possession, penalty. (H) Committee for Courts of Justice(H) Incorporated by Courts of Justice (HB972-Herring)02/05/20
notes: Decriminalizes simple marijuana possession and provides a civil penalty, payable to the Literary Fund, of no more than $100 for a first violation, $250 for a second violation, and $500 for a third or subsequent violation. Under current law, a first offense is punishable by a maximum fine of $500 and a maximum 30-day jail sentence, and subsequent offenses are a Class 1 misdemeanor. The bill reduces the criminal penalties for distribution and possession with intent to sell, give, or distribute marijuana. The bill creates a rebuttable presumption that a person who possesses no more than one ounce of marijuana possesses it for personal use and provides that the suspended sentence/substance abuse screening provisions apply only to criminal violations or to civil violations by a minor. The bill also limits forfeiture of property from the sale or distribution of marijuana to quantities of more than one pound; currently there is no minimum amount.
HB 312 - Gooditis - Nalozone or other opioid antagonist; communication of information by Board of Pharmacy. (H) Committee on Health, Welfare and Institutions(H) Stricken from docket by Health, Welfare and Institutions (22-Y 0-N)01/28/20
notes: Directs the Board of Pharmacy to include in each annual license renewal communication information about the dispensing, possession, and administration of naloxone or other opioid antagonist, including information about laws governing the dispensing, possession, and administration of naloxone or other opioid antagonist and civil immunity for individuals who administer naloxone or other opioid antagonist to a person believed to be experiencing an opioid overdose.
HB 347 - Davis - Commonwealth's medical cannabis program; SHHR to convene work group to review & make recommendation. (H) Committee on Health, Welfare and Institutions

(S) Committee on Rules
(S) Referred to Committee on Rules02/11/20
notes: Increases from one to two the number of pharmaceutical processor permits the Board of Pharmacy may issue or renew for each health service area in any year and allows each pharmaceutical processor to whom a permit has been issued by the Board of Pharmacy to operate up to two off-site dispensing facilities for the dispensing of cannabidiol oil and THC-A oil. The bill directs the Board of Pharmacy to issue additional permits to operate a pharmaceutical processor by September 1, 2020.
HB 378 - Rasoul - Comprehensive harm reduction programs; public health emergency, repeal sunset provision. (H) Committee on Health, Welfare and Institutions

(S) Committee on Finance and Appropriations
(S) Rereferred to Finance and Appropriations02/13/20
notes: Repeals the sunset on the program established in 2017 that allows the Commissioner of Health to establish and operate local or regional comprehensive harm reduction programs during a declared public health emergency that include a provision for the distribution of sterile hypodermic needles and syringes and the disposal of used hypodermic needles and syringes.
HB 481 - Kory - Marijuana; decriminalization of simple marijuana possession, penalty. (H) Committee for Courts of Justice(H) Incorporated by Courts of Justice (HB972-Herring)02/05/20
notes: Decriminalizes simple marijuana possession and provides a civil penalty of no more than $50 for a first violation, $100 for a second violation, and $250 for a third or subsequent violation. Current law imposes a maximum fine of $500 and a maximum 30-day jail sentence for a first offense, and subsequent offenses are a Class 1 misdemeanor. The bill provides that the suspended sentence/substance abuse screening provisions and driver's license suspension provisions apply only to criminal violations or to civil violations by a juvenile. The bill provides that a court may suspend a driver's license for a civil violation committed by an adult. A civil violation will be treated as a conviction for prohibitions on the purchase or transport of a handgun and disqualification for a concealed handgun permit.
HB 532 - Carr - Safe reporting of overdoses; immunity from prosecution. (H) Committee for Courts of Justice(H) Left in Courts of Justice02/11/20
notes: Provides that no individual (i) who sought or obtained emergency medical attention for himself or for another individual because of a drug or alcohol-related overdose or (ii) is experiencing a drug or alcohol-related overdose and another individual, in good faith, seeks or obtains emergency medical attention for such individual shall be prosecuted for unlawful purchase, possession, or consumption of alcohol, simple possession of a controlled substance, possession of marijuana, intoxication in public, or possession of controlled paraphernalia. Under current law, an affirmative defense against such offenses is available for an individual who sought or obtained emergency medical attention for himself or for another individual because of a drug-related or alcohol-related overdose. The bill also adds the statewide poison control system to the list of emergency care providers to whom individuals must contemporaneously report such overdoses in order to qualify for immunity from prosecution. The bill also states that no individual who is immune from prosecution pursuant to the provisions of the bill shall be found to be in violation of any term or condition of probation, parole, postrelease supervision, pretrial supervision, a suspended sentence, or bail, bond, or recognizance on the basis of evidence obtained as a result of an individual's seeking or obtaining emergency medical attention and that the real or personal property of an individual who is immune from prosecution that was used in connection with or derived from the specified offenses shall not be subject to forfeiture to the Commonwealth. The bill also provides that immunity from prosecution does not apply to an individual who seeks or obtains emergency medical attention for
HB 546 - Sickles - Prescribing of Schedule VI controlled substances; telemedicine, store-and-forward technologies. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/11/20
notes: Provides that electronic technology or media used for telemedicine services includes store-and-forward technologies and that, used in the context of prescribing Schedule VI controlled substances through telemedicine services, "store-and-forward technologies" means technologies that allow for the electronic transmission of medical information, including images, documents, or health histories, through a secure communications system.
HB 648 - Hurst - Prescription Monitoring Program; information disclosed to Emergency Department Information. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Passed Senate with amendments (40-Y 0-N)02/17/20
notes: Provides for the mutual exchange of information between the Prescription Monitoring Program and the Emergency Department Information Exchange and clarifies that nothing shall prohibit the redisclosure of confidential information from the Prescription Monitoring Program or any data or reports produced by the Prescription Monitoring Program disclosed to the Emergency Department Information Exchange to a prescriber in an electronic report generated by the Emergency Department Information Exchange so long as the electronic report complies with relevant federal law and regulations governing privacy of health information.
HB 650 - Hope - Naloxone or other opioid antagonist; possession and administration. (H) Committee on Health, Welfare and Institutions(H) Incorporated by Health, Welfare and Institutions (HB908-Hayes)02/04/20
notes: Provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, provided the administration is in good faith and absent gross negligence or willful and wanton misconduct.
HB 691 - Simonds - Prescription Drug Affordability Board and Office, etc.; established. (H) Committee on Health, Welfare and Institutions(H) Continued to 2021 in Health, Welfare and Institutions02/04/20
notes: Establishes the Prescription Drug Affordability Board to study, review, and regulate the cost of prescription drugs in the Commonwealth, in consultation with a stakeholder work group appointed by the Board. The bill also establishes the Office of the Prescription Drug Affordability Board to provide staffing and administrative support to the Prescription Drug Affordability Board.
HB 695 - Simonds - Reports of certain acts to school authorities; exclusion, possession of certain amount of marijuana. (H) Committee on Education(H) Incorporated by Education (HB257-Mullin)01/29/20
notes: Excludes from the incident reports required to be made to division superintendents and principals or their designees incidents involving the possession, for personal use and without the indicia of an intent to distribute, of less than one-quarter of one ounce of marijuana on a school bus, on school property, or at a school-sponsored activity.
HB 699 - Hope - Mandatory outpatient treatment; rescission of order. (H) Committee on Appropriations(H) Left in Appropriations02/11/20
notes: Clarifies the types of evidence that may be considered by a court in determining whether continued mandatory outpatient treatment is warranted; clarifies the criteria that a court is required to consider when reviewing or determining whether to rescind or continue a mandatory outpatient order or order for mandatory outpatient treatment following inpatient treatment; provides that if a person who is the subject of a mandatory outpatient treatment order or order authorizing discharge to mandatory outpatient treatment following inpatient treatment files a petition for rescission of the order, the court shall appoint an examiner to personally examine the person to determine whether he meets the criteria for inpatient admission or mandatory outpatient treatment; limits the frequency with which a person who is the subject of a mandatory outpatient treatment order or order authorizing discharge to mandatory outpatient treatment following inpatient treatment may petition for review of such order to no more than once during each 90-day period following entry of such order; and makes clear that a mandatory outpatient treatment order or order authorizing discharge to mandatory outpatient treatment following inpatient treatment remains in full force and effect unless rescinded by the court and that revocation of a person's agreement to abide by a mandatory outpatient treatment plan or discharge plan that has been approved by the court shall not rescind the mandatory outpatient treatment order or order authorizing discharge to mandatory outpatient treatment following inpatient treatment.
HB 700 - Hope - Mandatory outpatient treatment; eliminates patient consent. (H) Committee on Appropriations(H) Left in Appropriations02/11/20
notes: Eliminates the patient consent requirement for minors age 14 or older and adults before mandatory outpatient treatment may be ordered but there is no change in the requirement that a minor's parents must agree to abide by the minor's treatment plan.
HB 702 - Hope - Mandatory outpatient treatment; petition for review, efforts of the community services board. (H) Committee on Health, Welfare and Institutions(H) Continued to 2021 in Health, Welfare and Institutions02/04/20
notes: Clarifies that a community services board must make efforts to assist a person with complying with the provisions of a mandatory outpatient treatment order or order authorizing discharge to mandatory outpatient treatment following inpatient treatment and that only in cases in which a person fails to comply with a mandatory outpatient treatment or order authorizing discharge to mandatory outpatient treatment following inpatient treatment despite efforts of the community services board to assist the person may the community services board petition for review of the mandatory outpatient order or order authorizing discharge to mandatory outpatient treatment following inpatient treatment.
HB 791 - Plum - Comprehensive harm reduction programs; authority to establish and operate. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Assigned Education sub: Health02/17/20
notes: Repeals the sunset on the authority of the Commissioner of Health to establish and operate local or regional comprehensive harm reduction programs that include the distribution of sterile hypodermic needles and syringes and the disposal of used hypodermic needles and syringes; allows a local health department or other organization that promotes scientifically proven methods of mitigating health risks associated with drug use and other high-risk behaviors to establish comprehensive harm reduction programs; and eliminates the requirement that comprehensive harm reduction programs be located in communities for which data indicates an increase in or increased risk of transmission of HIV, viral hepatitis, or other blood-borne disease as a result of injection drug use. The bill includes an emergency clause.
HB 814 - Ward - TANF; eligibility for drug-related felonies. (H) Committee on Health, Welfare and Institutions(H) Incorporated by Health, Welfare and Institutions (HB566-Guzman)01/28/20
notes: Provides that a person who is otherwise eligible to receive Temporary Assistance for Needy Families (TANF) shall not be denied such assistance solely because he has been convicted of a felony offense of possession of a controlled substance in violation of 18.2-250, provided that such person is complying with, or has already complied with, all obligations imposed by the criminal court, is actively engaged in or has completed a substance abuse treatment program, participates in periodic drug screenings, and meets any other obligations as determined by the Department of Social Services.
HB 1261 - Hodges - Athletic trainers; naloxone or other opioid antagonist. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Assigned Education sub: Health Professions02/12/20
notes: Authorizes licensed athletic trainers to possess and administer naloxone or other opioid antagonist for overdose reversal pursuant to an oral or written order or standing protocol issued by the prescriber within the course of his professional practice.
HB 1263 - Hodges - Drug Control Act; adds certain chemicals to Schedule 1 of Act. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Passed Senate (40-Y 0-N)02/17/20
notes: Adds certain chemicals to Schedule I of the Drug Control Act. The Board of Pharmacy has added these substances to Schedule I in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule.
HB 1304 - Hodges - Pharmacy technicians and pharmacy technician trainees; registration. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Passed Senate (40-Y 0-N)02/17/20
notes: Amends eligibility criteria for registration as a pharmacy technician to include a requirement that (i) the individual has completed a training program that is (a) an accredited training program approved by the Board of Pharmacy, (b) operated through a federal agency or branch of the military, or (c) operated through the Department of Education's Career and Technical Education program and (ii) the applicant has successfully passed a national certification examination administered by the Pharmacy Technician Certification Board or the National Healthcareer Association. The bill defines "pharmacy technician trainee" and sets out requirements for registration as a pharmacy technician trainee.
HB 1365 - Leftwich - Imitation nicotine vapor products; manufacture, sale, or distribution, penalty. (H) Committee on Finance(H) Left in Finance02/11/20
notes: Prohibits the manufacture, sale, or distribution of any imitation nicotine vapor product, defined in the bill as any (i) counterfeit nicotine vapor product, also defined in the bill, or (ii) any liquid nicotine or nicotine vapor product that was not manufactured, prepared, compounded, or processed by a person registered with the U.S. Food and Drug Administration (FDA). The bill makes a first violation a Class 1 misdemeanor and a second or subsequent offense a Class 6 felony, provided that the accused was at liberty between each conviction and it is admitted, or found by the jury or judge before whom the person is tried, that the accused was previously convicted of a violation.
HB 1372 - Leftwich - Vapor products; licensing of retailers. (H) Committee on Finance(H) Continued to 2021 in Finance02/05/20
notes: Requires any person that engages in the retail sale of vapor products to register with the Department of Taxation as a retail dealer. The bill authorizes the Department to charge an application fee not to exceed its costs of enforcement and application processing. The bill provides for recordkeeping requirements and makes it a Class 1 misdemeanor to engage in fraud or misrepresentation in connection with an application.
HB 1404 - Leftwich - Canadian Prescription Drug Importation Program; established, report. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/11/20
notes: Establishes the Canadian Prescription Drug Importation Program, pending federal approval and certification from the Secretary of the U.S. Department of Health and Human Services. Under the Program, the Commissioner of Health is required to designate the Department of Health, the Commissioner, or another agency or officer of the Commonwealth; a licensed drug wholesaler; or a nonprofit, nonstock corporation established by the Department as a public instrumentality exercising public and essential governmental functions to (i) import prescription drugs from Canadian suppliers and (ii) distribute the imported prescription drugs to pharmacies or pharmacists in the Commonwealth that contract with the designated entity to make the imported prescription drugs available to residents of the Commonwealth at the cost prescribed in the contract. The measure provides that only prescription drugs that have the highest potential for cost savings to the Commonwealth shall be identified for importation. The Program will authorize the designated entity to purchase prescription drugs from a Canadian supplier and distribute the prescription drugs to pharmacists and pharmacies that are in-network under a health plan provided by a health carrier, state employee health plan or local choice plan, and the Medicaid program. Contracts between the pharmacist or pharmacy and the designated entity will set the price at which the prescription drugs are to be provided to covered individuals. The measure requires the Commissioner, by December 1, 2021, to review the proposed Program and, if the proposed Program is approved, to submit the proposed Program for federal review. The bill includes other provisions; please see the bill.
HB 1405 - Leftwich - Prescription drugs for the treatment of diabetes; price transparency, civil penalty. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/11/20
notes: Requires a manufacturer of a prescription drug indicated for use in the treatment of diabetes to report certain information to the Commissioner of Health regarding the cost of such prescription drugs and to report additional information when the price of such a drug increases beyond the increase in the medical care component of the Consumer Price Index for the preceding year. The bill also requires pharmacy benefits managers to report information to the Commissioner of Health regarding any rebates negotiated with a manufacturer for such drugs. The bill provides that such information reported to the Commissioner of Health will be managed by the nonprofit organization that administers the Virginia All-Payer Claims Database. The bill provides that the Board of Health may assess a civil penalty of up to $1,000 per week per violation, not to exceed a total of $50,000 per violation, against a manufacturer or pharmacy benefits manager that fails, within the Board's determination, to make a good faith effort to meet a reporting deadline. In addition, the bill requires pharmacy benefits managers to register with the State Corporation Commission and authorizes the Commission to revoke the registration of any pharmacy benefits manager that fails to comply with reporting requirements specified in the bill. The Board of Pharmacy is authorized to revoke the permit or registration of any manufacturer that fails to comply with the specified reporting requirements.
HB 1456 - Samirah - Medical assistance services; managed care organization contracts with pharmacy providers. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/11/20
notes: Requires the Department of Medical Assistance Services to require a managed care organization with which the Department enters into an agreement for the delivery of medical assistance services to include in any agreement between the managed care organization and an intermediary a provision prohibiting the intermediary from recouping direct and indirect remuneration fees with respect to a prescription.
HB 1459 - O'Quinn - Pharmacy benefits managers; managers to register with the Commissioner of the Bureau of Insurance. (H) Committee on Labor and Commerce(H) Incorporated by Labor and Commerce (HB1290-Hodges)02/04/20
notes: Requires pharmacy benefits managers to register with the Commissioner of the Bureau of Insurance. The measure prohibits a carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager from (i) causing or knowingly permitting the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue, deceptive, or misleading; (ii) charge a pharmacist or pharmacy a fee related to the adjudication of a claim; (iii) engaging, with the express intent or purpose of driving out competition or financially injuring competitors, in a pattern or practice of reimbursing retail community pharmacies or pharmacists in the Commonwealth consistently less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services; (iv) collecting or requiring a pharmacy or pharmacist to collect from an insured a copayment for a prescription drug at the point of sale in an amount that exceeds the lesser of the contracted copayment amount, the amount an individual would pay for a prescription drug if that individual was paying cash, or the contracted amount for the drug; (v) reimbursing a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same generic product identifier or generic code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration; (vi) penalize or give an inducement to a covered individual for the purpose of having the covere
HB 1460 - O'Quinn - Cannabidiol oil and THC-A oil; certification for use of oil. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Referred to Committee on Education and Health02/10/20
notes: Removes the requirement that a person be a Virginia resident to obtain a certification for cannabidiol oil and THC-A oil in Virginia. The bill requires pharmaceutical processors to dispense cannabidiol oil and THC-A oil to non-Virginia residents pursuant to a valid written certification issued by a Virginia practitioner.
HB 1465 - Gooditis - Naloxone; possession and administration, employee or person acting on behalf of a public place. (H) Committee on Health, Welfare and Institutions(H) Incorporated by Health, Welfare and Institutions (HB908-Hayes)02/04/20
notes: Provides that an employee or other person acting on behalf of a public place who has completed a training program on the administration of naloxone or other opioid antagonist may possess and administer naloxone or other opioid antagonist in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health. The bill defines "public place" as any area that is used or held out for use by the public, whether owned or operated by a public or private interest.
HB 1466 - Gooditis - Naloxone; possession and administration. (H) Committee on Health, Welfare and Institutions(H) Incorporated by Health, Welfare and Institutions (HB908-Hayes)02/04/20
notes: Provides that, notwithstanding any other law or regulation to the contrary, any person may possess and administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose.
HB 1468 - Gooditis - Secretary of Health and Human Resources; work group to study information about opioid overdoses. (H) Committee on Health, Welfare and Institutions(H) Stricken from docket by Health, Welfare and Institutions (22-Y 0-N)01/28/20
notes: Directs the Secretary of Health and Human Resources to convene a work group to (i) study the role of public safety answering points and regional Poison Control Centers in providing information and assistance to the public regarding opioid overdose and administration of naloxone or other opioid antagonist in emergency and nonemergency situations and (ii) develop recommendations for legislative or budget actions necessary to enhance the role of public safety answering points and regional Poison Control Centers in providing such information and assistance. The work group shall report its findings and recommendations to the Governor and the General Assembly by November 1, 2020.
HB 1498 - Sickles - Pharmaceutical Manufacturing Grant Program and Fund; created. (H) Committee on Appropriations

(S) Committee on Finance and Appropriations
(S) Rereferred to Finance and Appropriations02/13/20
notes: Creates the Pharmaceutical Manufacturing Grant Program to make grant payments to an eligible pharmaceutical manufacturer that makes a capital investment of at least $1 billion at a facility in Rockingham County and creates at least 152 new full-time jobs at the facility. The pharmaceutical manufacturer would be eligible for an aggregate of $7.5 million in grants paid out over a three-year period if it meets such performance parameters. The bill also makes available, subject to appropriation, $2.525 million to a comprehensive community college and baccalaureate public institutions of higher education in or near Rockingham County to support the workforce development needs of the manufacturer and other research and development companies in the area.
HB 1506 - Sickles - Pharmacists; initiating of treatment with and dispensing and administering of controlled substances. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Referred to Committee on Education and Health02/12/20
notes: Authorizes the prescribing, dispensing, and administration of certain controlled substances by a pharmacist, provided that such pharmacist prescribes, dispenses, or administers such controlled substances in accordance with a statewide protocol developed by the Board of Pharmacy in consultation with the Board of Medicine and set forth in regulations of the Board of Pharmacy. The bill clarifies that an accident and sickness insurance policy that provides reimbursement for a service that may be legally performed by a licensed pharmacist shall provide reimbursement for the prescribing, dispensing, or administration of controlled substances by a pharmacist when such prescribing, dispensing, or administration is in accordance with regulations of the Board of Pharmacy.
HB 1507 - Carroll Foy - Marijuana; possession. (H) Committee for Courts of Justice(H) Continued to 2021 in Courts of Justice02/05/20
notes: Possession of marijuana.
HB 1531 - Jenkins - Drug disposal; Bd. of Pharmacy to develop public awareness of proper methods. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Assigned Education sub: Health Professions02/12/20
notes: Requires all pharmacies and hospitals or clinics with an on-site pharmacy to participate in a drug disposal program.
HB 1654 - Helmer - Schedule VI controlled substances and hypodermic syringes and needles; limited-use license. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Referred to Committee on Education and Health02/10/20
notes: Allows the Board of Pharmacy to issue a limited-use license for the purpose of dispensing Schedule VI controlled substances and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, a nurse practitioner, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. The bill requires such nonprofit facilities to obtain a limited-use permit from the Board and comply with regulations for such a permit.
HB 1670 - O'Quinn - Pharmaceutical processors; cannabidiol oil, formulation may include oil from industrial hemp. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(S) Referred to Committee on Education and Health02/10/20
notes: Replaces the definitions of cannabidiol oil and THC-A oil with a definition for cannabis oil. The bill allows pharmaceutical processors to acquire industrial hemp grown and processed in Virginia from a registered industrial hemp dealer or processor and allows a pharmaceutical processor to process and formulate industrial hemp with cannabis plant extract into an allowable dosage.
HJ 39 - McGuire - Kratom; Board of Pharmacy to study whether it should be classified as a controlled substance. (H) Committee on Rules(H) Left in Rules02/11/20
notes: Directs the Board of Pharmacy to study whether Mitragyna speciosa, commonly known as kratom, should be classified as a controlled substance in the Commonwealth.
HJ 52 - Guzman - Prescription drugs; SHHR to convene work group to address cost to Virginians, etc. (H) Committee on Rules

(S) Committee on Rules
(S) Referred to Committee on Rules02/11/20
notes: Requests the Secretary of Health and Human Resources to study the establishment of a Prescription Drug Affordability Board with the authority to review and regulate the cost of prescription drugs in the Commonwealth.
HJ 130 - Heretick - Cannabis and medical cannabis; JLARC to study options for regulation of adult use. (H) Committee on Rules

(S) Committee on Rules
(S) Referred to Committee on Rules02/11/20
notes: Establishes the Joint Subcommittee to Study the Development of a Framework for Regulated Adult-Use of Cannabis and Medical Cannabis (Joint Subcommittee). The bill requires the Joint Subcommittee to (i) study and provide guidance on the potential creation of a Cannabis Control Commission to oversee licensing and regulation of industrial hemp, medical cannabis, and adult-use of cannabis; (ii) provide regulatory guidance on potential tax rates and revenue forecasts for retail and wholesale products; (iii) study and make recommendations regarding the issuance of initial cultivation and retail licenses; (iv) develop and recommend a fee structure and grandfathering process for current pharmaceutical processors; (v) study and recommend potential marijuana advertising regulations; (vi) study and determine appropriate public consumption venues and personal cultivation allowances; (vii) study funding and processing requirements for expungement of criminal records and rights restoration related to marijuana decriminalization; (viii) study and recommend methods for diversifying ownership of the marijuana market; (ix) assess the California, Massachusetts, and Illinois marijuana programs and their effectiveness in transferring economic prosperity to disproportionately affected areas; (x) study the potential development of a community reinvestment fund; and (xi) review and analyze National Highway Traffic Safety Administration studies on marijuana-related impairment.
HJ 132 - Herring - Cannabis and medical cannabis; joint subcommittee to study development of framework for regulation. (H) Committee on Rules(H) Left in Rules02/11/20
notes: Study; Joint Subcommittee to Study the Development of a Framework for Regulated Adult-Use of Cannabis and Medical Cannabis; report.
SB 2 - Ebbin - Marijuana; decriminalization of simple possession, civil penalty. (H) Committee for Courts of Justice

(S) Committee on Finance and Appropriations
(H) Referred to Committee for Courts of Justice02/14/20
notes: Decriminalizes simple marijuana possession and provides a civil penalty of no more than $50. Current law imposes a maximum fine of $500 and a maximum 30-day jail sentence for a first offense, and subsequent offenses are a Class 1 misdemeanor. The bill provides that the suspended sentence and substance abuse screening provisions and driver's license suspension provisions apply only to criminal violations or to civil violations by a juvenile. The bill defines marijuana to include hashish oil. The bill raises the threshold amount of marijuana subject to the offense of distribution or possession with intent to distribute from one-half ounce to one ounce. The bill also allows a person to petition for expungement of convictions and deferred disposition dismissals for marijuana possession when all court costs and fines and orders of restitution have been paid. The bill contains technical amendments.
SB 52 - Stanley - Opioid addiction treatment pilot program; DBHDS, et al., to establish in Planning District 12. (H) Committee on Health, Welfare and Institutions

(S) Committee on Finance and Appropriations
(H) Referred to Committee on Health, Welfare and Institutions02/13/20
notes: Requires the Department of Behavioral Health and Developmental Services (the Department), in partnership with community services boards, a hospital licensed in the Commonwealth, and telemedicine networks, to establish a two-year pilot program in Planning District 12 designed to provide comprehensive treatment and recovery services to uninsured or underinsured individuals suffering from opioid addiction or opioid-related disorders. The bill requires the Department and its partners to collaborate with a work group established by the Department of interested stakeholders to develop the pilot program.
SB 61 - Marsden - Custody and visitation arrangements; use of cannabidiol oil or THC-A oil by foster parent, etc. (S) Committee on the Judiciary(S) Passed by indefinitely in Judiciary (13-Y 0-N)01/15/20
notes: Provides that the use of cannabidiol oil or THC-A oil by a parent in a custody or visitation case shall not serve as the sole basis for the denial or restriction of custody or visitation, if such parent has a written certification by a practitioner attesting to the benefit of such use. The bill further provides that such use by a foster parent shall not be the sole reason a child is removed from a foster parent and that such use by a prospective foster parent shall not be the sole reason to deny such prospective foster parent eligibility to become a foster parent. The bill also provides that such use by a petitioner for adoption shall not be the sole reason for the denial of a final order of adoption by a circuit court.
SB 118 - Peake - Underage alcoholic possession, etc.; expungement of certain offenses. (S) Committee on the Judiciary(S) Incorporated by Judiciary (SB608-Norment) (13-Y 0-N)01/29/20
notes: Allows a person to petition for expungement of a deferred disposition dismissal for underage alcohol possession or using a false ID to obtain alcohol when the offense occurred prior to the person's twenty-first birthday, all court costs and fines and orders of restitution have been satisfied, and the person seeking the expungement is at least 21 years of age and has no other alcohol-related convictions. The bill provides that any person seeking expungement of an alcohol-related charge shall be assessed a $150 fee, which shall be paid into the state treasury and credited to the Department of State Police.
SB 155 - Favola - TANF; eligibility for drug-related felonies. (S) Committee on Rehabilitation and Social Services(S) Incorporated by Rehabilitation and Social Services (SB124-Locke) (15-Y 0-N)01/10/20
notes: Provides that a person who is otherwise eligible to receive Temporary Assistance for Needy Families (TANF) shall not be denied such assistance solely because he has been convicted of a felony offense of possession of a controlled substance in violation of 18.2-250, provided that such person is complying with, or has already complied with, all obligations imposed by the criminal court, is actively engaged in or has completed a substance abuse treatment program, participates in periodic drug screenings, and meets any other obligations as determined by the Department of Social Services.
SB 185 - Dunnavant - Nursing homes, hospices, etc.; possession and administration of cannabidiol or THC-A. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(H) Assigned HWI sub: Health02/13/20
notes: Allows nursing home and assisted living facility staff members who are authorized to possess, distribute, or administer medications to residents to store, dispense, or administer cannabidiol oil or THC-A oil to a resident who has been issued a valid written certification for such medication.
SB 251 - Edwards - Pharmacy benefits managers; licensure and regulation. (H) Committee on Labor and Commerce

(S) Committee on Commerce and Labor
(H) Referred to Committee on Labor and Commerce02/18/20
notes: Provides that, beginning January 1, 2021, no person is authorized to provide pharmacy benefits management services or otherwise act as a pharmacy benefits manager without first obtaining a license from the State Corporation Commission. Such licenses are to be renewed annually. The bill also imposes recordkeeping and reporting requirements and provides that information or data acquired therefrom is considered proprietary and confidential and is not subject to the Virginia Freedom of Information Act.
SB 252 - Edwards - Pharmacy benefit managers; licensure and regulation. (S) Committee on Commerce and Labor(S) Incorporated by Commerce and Labor (SB251-Edwards) (15-Y 0-N)01/27/20
notes: Provides that, beginning January 1, 2021, no person is authorized to provide pharmacy benefit management services or otherwise act as a pharmacy benefit manager without first obtaining a license from the State Corporation Commission. Such licenses are to be renewed annually. The bill prohibits a pharmacy benefit manager from participating in spread pricing, defined in the bill, and provides that except for any agreed-upon administrative fee, all funds, including any rebates received by the pharmacy benefit manager in relation to providing pharmacy benefit management services for a carrier, will be distributed to the carrier.
SB 270 - Bell - Pharmacy; practice, regulation by Board of Pharmacy, report. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(H) Assigned HWI sub: Health Professions02/16/20
notes: Provides that compounding of drugs provided to the Department of Corrections for the purpose of carrying out an execution by lethal injection shall constitute the practice of pharmacy and be subject to the requirements of the Drug Control Act and the jurisdiction of the Board of Pharmacy. The bill provides that only outsourcing facilities may compound such drugs; currently, both pharmacies and outsourcing facilities may compound such drugs. The bill also clarifies that the Board of Pharmacy may inspect any pharmacy or other place where drugs, cosmetics, or devices are manufactured, stored, or dispensed in response to complaints received by the Board, in any case in which the Board has reason to believe that the pharmacy or such other place has violated any state or federal law or as otherwise deemed necessary by the Board to protect the health and safety of the public. The bill amends the membership of the Board of Health to include a pharmacist with experience in compounding, requires the Board of Health to educate the public about safe use of compounded drugs, and requires the Board of Health and the Board of Pharmacy to report annually to the Governor and the General Assembly on actions taken to (i) ensure the safety and quality of compounded drugs produced by compounding pharmacies and outsourcing facilities located in the Commonwealth and compounding pharmacies and outsourcing facilities located outside the Commonwealth that provide compounded drugs to patients in the Commonwealth; (ii) reduce illegal use of opioids and opioid abuse in the Commonwealth; and (iii) implement provisions of and ensure compliance with the requirements of Title II of the federal Drug Supply Chain Security Act of 2013 related to prescription drug identifi
SB 976 - Marsden - Pharmaceutical processors; operation of cannabis dispensing facilities. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(H) Referred to Committee on Health, Welfare and Institutions02/13/20
notes: Replaces the definitions of cannabidiol oil and THC-A oil with a definition for cannabis oil. The bill requires the Board of Pharmacy to establish a pharmacist-to-pharmacist-technician supervision ratio of one to eight for pharmaceutical processors. The bill allows practitioners to utilize telemedicine in evaluating and treating patients related to the issuance of written certifications for the use of cannabis oil. The bill permits pharmaceutical processors to establish up to five off-site dispensing locations within the health service area of the pharmaceutical processor. The bill directs the Board of Pharmacy to require that, after processing and before dispensing cannabidiol oil and THC-A oil, a pharmaceutical processor make a homogenized sample available from each batch of product for testing at an independent laboratory meeting board requirements. The bill directs the Board of Pharmacy to adopt regulations for the dispensing of unprocessed cannabis flower in the same manner as cannabis oil. The bill specifies that a licensed pharmacist shall only be required on the premises of the pharmaceutical processor during dispensing hours and during the production of cannabis oil and may authorize certain employee access to secured areas designated for cultivation and extraction and other areas approved by the Board.
SB 1045 - Hashmi - Cannabidiol oil and THC-A oil; sample testing. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(H) Assigned HWI sub: Health Professions02/13/20
notes: Directs the Board of Pharmacy to require that, after processing and before dispensing cannabidiol oil and THC-A oil, a pharmaceutical processor make a homogenized sample available from each batch of product for testing at an independent laboratory meeting Board requirements.